vs
Antero Midstream Corp（AM）与Esperion Therapeutics, Inc.（ESPR）财务数据对比。点击上方公司名可切换其他公司
Antero Midstream Corp的季度营收约是Esperion Therapeutics, Inc.的1.7倍（$291.1M vs $168.4M），Esperion Therapeutics, Inc.同比增速更快（143.7% vs -7.3%），过去两年Esperion Therapeutics, Inc.的营收复合增速更高（10.6% vs 3.9%）
Antero Midstream Corp是美国能源企业，注册地为特拉华州，总部设于科罗拉多州丹佛市。公司全部油气储量均位于阿巴拉契亚盆地，采用水力压裂技术开采，核心业务涵盖油气勘探开发相关领域。
Esperion Therapeutics, Inc.是一家上市美国药企，专注开发用于降低低密度脂蛋白胆固醇的口服小分子药物苯哌多酸，公司总部位于密歇根州安娜堡，目前核心研发管线围绕这款降脂创新药物推进，深耕血脂异常治疗领域的创新药物开发。
AM vs ESPR — 直观对比
营收规模更大
AM
是对方的1.7倍
$168.4M
营收增速更快
ESPR
高出151.1%
-7.3%
两年增速更快
ESPR
近两年复合增速
3.9%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $291.1M | $168.4M |
| 净利润 | $120.7M | — |
| 毛利率 | — | — |
| 营业利润率 | 60.9% | 50.6% |
| 净利率 | 41.5% | — |
| 营收同比 | -7.3% | 143.7% |
| 净利润同比 | 2.1% | — |
| 每股收益（稀释后） | $0.25 | $0.32 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMESPR
| Q1 26 | $291.1M | — | ||
| Q4 25 | $297.0M | $168.4M | ||
| Q3 25 | $294.8M | $87.3M | ||
| Q2 25 | $305.5M | $82.4M | ||
| Q1 25 | $291.1M | $65.0M | ||
| Q4 24 | $287.5M | $69.1M | ||
| Q3 24 | $269.9M | $51.6M | ||
| Q2 24 | $269.8M | $73.8M |
净利润AMESPR
| Q1 26 | $120.7M | — | ||
| Q4 25 | $51.9M | — | ||
| Q3 25 | $116.0M | $-31.3M | ||
| Q2 25 | $124.5M | $-12.7M | ||
| Q1 25 | $120.7M | $-40.5M | ||
| Q4 24 | $111.2M | — | ||
| Q3 24 | $99.7M | $-29.5M | ||
| Q2 24 | $86.0M | $-61.9M |
营业利润率AMESPR
| Q1 26 | 60.9% | — | ||
| Q4 25 | 33.8% | 50.6% | ||
| Q3 25 | 61.2% | -11.4% | ||
| Q2 25 | 61.0% | 8.6% | ||
| Q1 25 | 60.9% | -34.0% | ||
| Q4 24 | 61.8% | -6.4% | ||
| Q3 24 | 60.2% | -31.0% | ||
| Q2 24 | 56.6% | 3.5% |
净利率AMESPR
| Q1 26 | 41.5% | — | ||
| Q4 25 | 17.5% | — | ||
| Q3 25 | 39.3% | -35.9% | ||
| Q2 25 | 40.8% | -15.4% | ||
| Q1 25 | 41.5% | -62.2% | ||
| Q4 24 | 38.7% | — | ||
| Q3 24 | 37.0% | -57.2% | ||
| Q2 24 | 31.9% | -83.9% |
每股收益（稀释后）AMESPR
| Q1 26 | $0.25 | — | ||
| Q4 25 | $0.11 | $0.32 | ||
| Q3 25 | $0.24 | $-0.16 | ||
| Q2 25 | $0.26 | $-0.06 | ||
| Q1 25 | $0.25 | $-0.21 | ||
| Q4 24 | $0.23 | $-0.14 | ||
| Q3 24 | $0.21 | $-0.15 | ||
| Q2 24 | $0.18 | $-0.33 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $180.4M | $167.9M |
| 总债务越低越好 | $3.2B | — |
| 股东权益账面价值 | $2.0B | $-302.0M |
| 总资产 | $5.9B | $465.9M |
| 负债/权益比越低杠杆越低 | 1.63× | — |
8季度趋势，按日历期对齐
现金及短期投资AMESPR
| Q1 26 | $180.4M | — | ||
| Q4 25 | $180.4M | $167.9M | ||
| Q3 25 | — | $92.4M | ||
| Q2 25 | — | $86.1M | ||
| Q1 25 | — | $114.6M | ||
| Q4 24 | — | $144.8M | ||
| Q3 24 | — | $144.7M | ||
| Q2 24 | — | $189.3M |
总债务AMESPR
| Q1 26 | $3.2B | — | ||
| Q4 25 | $3.2B | — | ||
| Q3 25 | $3.0B | — | ||
| Q2 25 | $3.0B | — | ||
| Q1 25 | $3.1B | — | ||
| Q4 24 | $3.1B | — | ||
| Q3 24 | $3.2B | — | ||
| Q2 24 | $3.2B | — |
股东权益AMESPR
| Q1 26 | $2.0B | — | ||
| Q4 25 | $2.0B | $-302.0M | ||
| Q3 25 | $2.1B | $-451.4M | ||
| Q2 25 | $2.1B | $-433.5M | ||
| Q1 25 | $2.1B | $-426.2M | ||
| Q4 24 | $2.1B | $-388.7M | ||
| Q3 24 | $2.1B | $-370.2M | ||
| Q2 24 | $2.1B | $-344.2M |
总资产AMESPR
| Q1 26 | $5.9B | — | ||
| Q4 25 | $5.9B | $465.9M | ||
| Q3 25 | $5.7B | $364.0M | ||
| Q2 25 | $5.7B | $347.1M | ||
| Q1 25 | $5.8B | $324.0M | ||
| Q4 24 | $5.8B | $343.8M | ||
| Q3 24 | $5.8B | $314.1M | ||
| Q2 24 | $5.8B | $352.3M |
负债/权益比AMESPR
| Q1 26 | 1.63× | — | ||
| Q4 25 | 1.63× | — | ||
| Q3 25 | 1.46× | — | ||
| Q2 25 | 1.45× | — | ||
| Q1 25 | 1.49× | — | ||
| Q4 24 | 1.47× | — | ||
| Q3 24 | 1.49× | — | ||
| Q2 24 | 1.50× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $198.9M | $45.2M |
| 自由现金流经营现金流 - 资本支出 | $186.9M | — |
| 自由现金流率自由现金流/营收 | 64.2% | — |
| 资本支出强度资本支出/营收 | 11.1% | 0.0% |
| 现金转化率经营现金流/净利润 | 1.65× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流AMESPR
| Q1 26 | $198.9M | — | ||
| Q4 25 | $255.5M | $45.2M | ||
| Q3 25 | $212.8M | $-4.3M | ||
| Q2 25 | $265.2M | $-31.4M | ||
| Q1 25 | $198.9M | $-22.6M | ||
| Q4 24 | $232.7M | $-35.0M | ||
| Q3 24 | $184.9M | $-35.3M | ||
| Q2 24 | $215.8M | $-7.2M |
自由现金流AMESPR
| Q1 26 | $186.9M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $184.3M | $-35.5M | ||
| Q2 24 | $147.2M | $-7.3M |
自由现金流率AMESPR
| Q1 26 | 64.2% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 68.3% | -68.7% | ||
| Q2 24 | 54.6% | -9.9% |
资本支出强度AMESPR
| Q1 26 | 11.1% | — | ||
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.0% | ||
| Q4 24 | 0.0% | 0.0% | ||
| Q3 24 | 0.2% | 0.3% | ||
| Q2 24 | 25.4% | 0.1% |
现金转化率AMESPR
| Q1 26 | 1.65× | — | ||
| Q4 25 | 4.92× | — | ||
| Q3 25 | 1.84× | — | ||
| Q2 25 | 2.13× | — | ||
| Q1 25 | 1.65× | — | ||
| Q4 24 | 2.09× | — | ||
| Q3 24 | 1.85× | — | ||
| Q2 24 | 2.51× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AM
| Gathering and compression–Antero Resources | $238.0M | 82% |
| Other | $52.3M | 18% |
| Water handling–third party | $505.0K | 0% |
| Gathering and compression–third party | $295.0K | 0% |
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
